Other Species / Isoforms
  gp130 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
N43
PVVQLHSNFTAVCVL
0 1
gp130 (human) PVVQLHSNFTAVCVL N43
gp130 iso2 (human) PVVQLHSNFTAVCVL N43
gp130 iso3 (human) PVVQLHSNFTAVCVL N43
gp130 iso4 (human) PVVQLHSNFTAVCVL N43
gp130 (mouse) PVVQRGSnFTAICVL N43-ng
gp130 (rat) PVVQRGSNFTATCVL N43
N61
CMDYFHVNANYIVWK
0 1
gp130 (human) CMDYFHVNANYIVWK N61
gp130 iso2 (human) CMDYFHVNANYIVWK N61
gp130 iso3 (human) CMDYFHVNANYIVWK N61
gp130 iso4 (human) gap -
gp130 (mouse) CLQHYYVnASYIVWK N61-ng
gp130 (rat) CLQVYSVNATYIVWK N61
T69
ANYIVWKTNHFTIPK
0 1
gp130 (human) ANYIVWKTNHFTIPK T69
gp130 iso2 (human) ANYIVWKTNHFTIPK T69
gp130 iso3 (human) ANYIVWKTNHFTIPK T69
gp130 iso4 (human) gap -
gp130 (mouse) ASYIVWKtNHAAVPR T69-p
gp130 (rat) ATYIVWKTNHVAVPK T69
N83
KEQYTIINRTASSVT
0 1
gp130 (human) KEQYTIINRTASSVT N83
gp130 iso2 (human) KEQYTIINRTASSVT N83
gp130 iso3 (human) KEQYTIINRTASSVT N83
gp130 iso4 (human) gap -
gp130 (mouse) REQVTVInRTTSSVT N83-ng
gp130 (rat) KEQVTVINRTASSVT N83
K140-ub
SCIVNEGkKMRCEWD
0 1
gp130 (human) SCIVNEGkKMRCEWD K140-ub
gp130 iso2 (human) SCIVNEGKKMRCEWD K140
gp130 iso3 (human) SCIVNEGKKMRCEWD K140
gp130 iso4 (human) under review -
gp130 (mouse) TCIVNEGKNMLCQWD K140
gp130 (rat) SCIVNEGKNMLCQWD K140
N157
RETHLETNFTLKSEW
0 1
gp130 (human) RETHLETNFTLKSEW N157
gp130 iso2 (human) RETHLETNFTLKSEW N157
gp130 iso3 (human) RETHLETNFTLKSEW N157
gp130 iso4 (human) gap -
gp130 (mouse) RETYLETnYTLKSEW N157-ng
gp130 (rat) RETYLETNYTLKSEW N157
K168-ub
KSEWATHkFADCKAK
0 1
gp130 (human) KSEWATHkFADCKAK K168-ub
gp130 iso2 (human) KSEWATHKFADCKAK K168
gp130 iso3 (human) KSEWATHKFADCKAK K168
gp130 iso4 (human) under review -
gp130 (mouse) KSEWATEKFPDCQSK K168
gp130 (rat) KSEWATEKFPDCRTK K168
N227
VKPNPPHNLSVINSE
0 1
gp130 (human) VKPNPPHNLSVINSE N227
gp130 iso2 (human) VKPNPPHNLSVINSE N227
gp130 iso3 (human) VKPNPPHNLSVINSE N227
gp130 iso4 (human) LKPNPPHNLSVINSE N61
gp130 (mouse) VKPTPPYnLSVTNSE N225-ng
gp130 (rat) VKPSPPHNLSVTNSE N226
Y309-p
MKEDGKGyWSDWSEE
0 2
gp130 (human) MKEDGKGyWSDWSEE Y309-p
gp130 iso2 (human) MKEDGKGYWSDWSEE Y309
gp130 iso3 (human) MKEDGKGYWSDWSEE Y309
gp130 iso4 (human) MKEDGKGyWSDWSEE Y143-p
gp130 (mouse) IKDSGKGYWSDWSEE Y307
gp130 (rat) IKENGKGYWSDWSEE Y308
Y322-p
EEASGITyEDRPSKA
0 1
gp130 (human) EEASGITyEDRPSKA Y322-p
gp130 iso2 (human) EEASGITYEDNIASF Y322
gp130 iso3 (human) EEASGITYEDRPSKA Y322
gp130 iso4 (human) EEASGITYEDKLKNT Y156
gp130 (mouse) EEASGTTYEDRPSRP Y320
gp130 (rat) EEASGTTYEDRPSKA Y321
N390
NATKLTVNLTNDRyL
0 1
gp130 (human) NATKLTVNLTNDRyL N390
gp130 iso2 (human) gap -
gp130 iso3 (human) NATKLTVNLTNDRYL N390
gp130 iso4 (human) gap -
gp130 (mouse) TGTELTVnLTNDRYV N388-ng
gp130 (rat) NGTELIVNLTNNRYV N389
Y396-p
VNLTNDRyLATLTVR
0 1
gp130 (human) VNLTNDRyLATLTVR Y396-p
gp130 iso2 (human) gap -
gp130 iso3 (human) VNLTNDRYLATLTVR Y396
gp130 iso4 (human) gap -
gp130 (mouse) VnLTNDRYVASLAAR Y394
gp130 (rat) VNLTNNRYVASLAAR Y395
H478
QQEDGTVHRTYLRGN
0 1
gp130 (human) QQEDGTVHRTYLRGN H478
gp130 iso2 (human) gap -
gp130 iso3 (human) gap -
gp130 iso4 (human) gap -
gp130 (mouse) QQEDATVnRTHLRGR N476-ng
gp130 (rat) QQEDGTVNRTHLRGS N477
K649-ub
NKRDLIKkHIWPNVP
0 3
gp130 (human) NKRDLIKkHIWPNVP K649-ub
gp130 iso2 (human) gap -
gp130 iso3 (human) NKRDLIKKHIWPNVP K588
gp130 iso4 (human) gap -
gp130 (mouse) NKRDLIKkHIWPNVP K647-ub
gp130 (rat) NKRDLIKKHIWPNVP K648
S661-p
NVPDPSKsHIAQWsP
0 1
gp130 (human) NVPDPSKsHIAQWsP S661-p
gp130 iso2 (human) gap -
gp130 iso3 (human) NVPDPSKSHIAQWSP S600
gp130 iso4 (human) gap -
gp130 (mouse) NVPDPSKSHIAQWsP S659
gp130 (rat) NVPDPSKSHIAQWsP S660
S667-p
KsHIAQWsPHtPPRH
Upstream
0 24
Treatment
  • BI_4834
  • nocodazole
gp130 (human) KsHIAQWsPHtPPRH S667-p
gp130 iso2 (human) gap -
gp130 iso3 (human) KSHIAQWSPHTPPRH S606
gp130 iso4 (human) gap -
gp130 (mouse) KSHIAQWsPHtPPRH S665-p
gp130 (rat) KSHIAQWsPHTPPRH S666-p
T670-p
IAQWsPHtPPRHNFN
Upstream
0 20
Regulatory protein:
  • TBK1 (human)
Treatment
  • BI_4834
  • nocodazole
gp130 (human) IAQWsPHtPPRHNFN T670-p
gp130 iso2 (human) gap -
gp130 iso3 (human) IAQWSPHTPPRHNFN T609
gp130 iso4 (human) gap -
gp130 (mouse) IAQWsPHtPPRHNFN T668-p
gp130 (rat) IAQWsPHTPPRHNFN T669
S678-p
PPRHNFNsKDQMYSD
0 2
gp130 (human) PPRHNFNsKDQMYSD S678-p
gp130 iso2 (human) gap -
gp130 iso3 (human) PPRHNFNSKDQMYSD S617
gp130 iso4 (human) gap -
gp130 (mouse) PPRHNFNSKDQMYSD S676
gp130 (rat) PPRHNFNSKDQMYSD S677
K702-ub
EIEANDKkPFPEDLK
0 1
gp130 (human) EIEANDKkPFPEDLK K702-ub
gp130 iso2 (human) under review -
gp130 iso3 (human) EIEANDKKPFPEDLK K641
gp130 iso4 (human) under review -
gp130 (mouse) EIEANNKKPCPDDLK K700
gp130 (rat) EIEANNKKPCPDDLK K701
S710-p
PFPEDLKsLDLFkKE
0 5
gp130 (human) PFPEDLKsLDLFkKE S710-p
gp130 iso2 (human) gap -
gp130 iso3 (human) PFPEDLKSLDLFKKE S649
gp130 iso4 (human) gap -
gp130 (mouse) PCPDDLKsVDLFKKE S708-p
gp130 (rat) PCPDDLKSLDLFKKE S709
K715-ub
LKsLDLFkKEkINTE
0 1
gp130 (human) LKsLDLFkKEkINTE K715-ub
gp130 iso2 (human) under review -
gp130 iso3 (human) LKSLDLFKKEKINTE K654
gp130 iso4 (human) under review -
gp130 (mouse) LKsVDLFKKEKVSTE K713
gp130 (rat) LKSLDLFKKEKISTE K714
K718-ub
LDLFkKEkINTEGHS
0 1
gp130 (human) LDLFkKEkINTEGHS K718-ub
gp130 iso2 (human) under review -
gp130 iso3 (human) LDLFKKEKINTEGHS K657
gp130 iso4 (human) under review -
gp130 (mouse) VDLFKKEKVSTEGHS K716
gp130 (rat) LDLFKKEKISTEGHS K717
Y759-p
NTSSTVQyStVVHsG
Upstream
Downstream
12 3
Effects on Modified Protein
  • activity, induced
  • activity, inhibited
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • cell differentiation, altered
  • transcription, altered
Treatment
  • IL-6
gp130 (human) NTSSTVQyStVVHsG Y759-p
gp130 iso2 (human) gap -
gp130 iso3 (human) NTSSTVQYSTVVHSG Y698
gp130 iso4 (human) gap -
gp130 (mouse) STASTVQySTVVHSG Y757-p
gp130 (rat) STASTVQYSTVVHSG Y758
T761-p
SSTVQyStVVHsGyR
0 1
gp130 (human) SSTVQyStVVHsGyR T761-p
gp130 iso2 (human) gap -
gp130 iso3 (human) SSTVQYSTVVHSGYR T700
gp130 iso4 (human) gap -
gp130 (mouse) ASTVQySTVVHSGYR T759
gp130 (rat) ASTVQYSTVVHSGYR T760
S765-p
QyStVVHsGyRHQVP
0 1
gp130 (human) QyStVVHsGyRHQVP S765-p
gp130 iso2 (human) gap -
gp130 iso3 (human) QYSTVVHSGYRHQVP S704
gp130 iso4 (human) gap -
gp130 (mouse) QySTVVHSGYRHQVP S763
gp130 (rat) QYSTVVHSGYRHQVP S764
Y767-p
StVVHsGyRHQVPSV
Upstream
Downstream
2 6
Effects on Biological Processes:
  • cell cycle regulation
  • transcription, altered
Treatment
  • Su11274
gp130 (human) StVVHsGyRHQVPSV Y767-p
gp130 iso2 (human) gap -
gp130 iso3 (human) STVVHSGYRHQVPSV Y706
gp130 iso4 (human) gap -
gp130 (mouse) STVVHSGYRHQVPSV Y765
gp130 (rat) STVVHSGYRHQVPSV Y766
S780-p
SVQVFSRsEsTQPLL
0 2
gp130 (human) SVQVFSRsEsTQPLL S780-p
gp130 iso2 (human) gap -
gp130 iso3 (human) SVQVFSRSESTQPLL S719
gp130 iso4 (human) gap -
gp130 (mouse) SVQVFSRsEstQPLL S778-p
gp130 (rat) SVQVFSRSESTQPLL S779
S782-p
QVFSRsEsTQPLLDS
Upstream
Downstream
4 3
Effects on Modified Protein
  • protein degradation
  • receptor internalization, altered
  • receptor recycling, induced
Phosphatases, in vitro:
  • PPP2CA (human)
Treatment
  • LIF
  • MG115
  • okadaic_acid
  • phorbol_ester
  • tautomycin
gp130 (human) QVFSRsEsTQPLLDS S782-p
gp130 iso2 (human) gap -
gp130 iso3 (human) QVFSRSESTQPLLDS S721
gp130 iso4 (human) gap -
gp130 (mouse) QVFSRsEstQPLLDS S780-p
gp130 (rat) QVFSRSESTQPLLDS S781
T783
VFSRsEsTQPLLDSE
0 2
gp130 (human) VFSRsEsTQPLLDSE T783
gp130 iso2 (human) gap -
gp130 iso3 (human) VFSRSESTQPLLDSE T722
gp130 iso4 (human) gap -
gp130 (mouse) VFSRsEstQPLLDSE T781-p
gp130 (rat) VFSRSESTQPLLDSE T782
G804
QLVDHVDGGDGILPR
0 1
gp130 (human) QLVDHVDGGDGILPR G804
gp130 iso2 (human) gap -
gp130 iso3 (human) QLVDHVDGGDGILPR G743
gp130 iso4 (human) gap -
gp130 (mouse) QLVDSVDGGDEILPR G802
gp130 (rat) QLVDSVDsGDEILPR S803-p
Y814-p
GILPRQQyFKQNCsQ
Downstream
2 1
Effects on Biological Processes:
  • cell cycle regulation
  • transcription, altered
gp130 (human) GILPRQQyFKQNCsQ Y814-p
gp130 iso2 (human) gap -
gp130 iso3 (human) GILPRQQYFKQNCSQ Y753
gp130 iso4 (human) gap -
gp130 (mouse) EILPRQPYFKQNCsQ Y812
gp130 (rat) EILPRQQYFKQSCSQ Y813
S820-p
QyFKQNCsQHEssPD
0 3
gp130 (human) QyFKQNCsQHEssPD S820-p
gp130 iso2 (human) gap -
gp130 iso3 (human) QYFKQNCSQHESSPD S759
gp130 iso4 (human) gap -
gp130 (mouse) PYFKQNCsQPEACPE S818-p
gp130 (rat) QYFKQSCSQPGASPD S819
S824-p
QNCsQHEssPDISHF
0 1
gp130 (human) QNCsQHEssPDISHF S824-p
gp130 iso2 (human) gap -
gp130 iso3 (human) QNCSQHESSPDISHF S763
gp130 iso4 (human) gap -
gp130 (mouse) QNCsQPEACPEISHF A822
gp130 (rat) QSCSQPGASPDVSHF A823
S825-p
NCsQHEssPDISHFE
0 2
gp130 (human) NCsQHEssPDISHFE S825-p
gp130 iso2 (human) gap -
gp130 iso3 (human) NCSQHESSPDISHFE S764
gp130 iso4 (human) gap -
gp130 (mouse) NCsQPEACPEISHFE C823
gp130 (rat) SCSQPGASPDVSHFE S824
K835-ub
ISHFERSkQVssVNE
0 1
gp130 (human) ISHFERSkQVssVNE K835-ub
gp130 iso2 (human) under review -
gp130 iso3 (human) ISHFERSKQVSSVNE K774
gp130 iso4 (human) under review -
gp130 (mouse) ISHFERSNQVLSGNE N833
gp130 (rat) VSHFERSSQVPsGSE S834
S838-p
FERSkQVssVNEEDF
0 2
gp130 (human) FERSkQVssVNEEDF S838-p
gp130 iso2 (human) gap -
gp130 iso3 (human) FERSKQVSSVNEEDF S777
gp130 iso4 (human) gap -
gp130 (mouse) FERSNQVLSGNEEDF L836
gp130 (rat) FERSSQVPsGSEEDF P837
S839-p
ERSkQVssVNEEDFV
Upstream
0 7
Treatment
  • ischemia
gp130 (human) ERSkQVssVNEEDFV S839-p
gp130 iso2 (human) gap -
gp130 iso3 (human) ERSKQVSSVNEEDFV S778
gp130 iso4 (human) gap -
gp130 (mouse) ERSNQVLSGNEEDFV S837
gp130 (rat) ERSSQVPsGSEEDFV S838-p
K849-m1
EEDFVRLkQQIsDHI
0 1
gp130 (human) EEDFVRLkQQIsDHI K849-m1
gp130 iso2 (human) gap -
gp130 iso3 (human) EEDFVRLKQQISDHI K788
gp130 iso4 (human) gap -
gp130 (mouse) EEDFVRLKQQQVSDH K847
gp130 (rat) EEDFVRLKQQQVSDH K848
K849-ub
EEDFVRLkQQIsDHI
0 1
gp130 (human) EEDFVRLkQQIsDHI K849-ub
gp130 iso2 (human) under review -
gp130 iso3 (human) EEDFVRLKQQISDHI K788
gp130 iso4 (human) under review -
gp130 (mouse) EEDFVRLKQQQVSDH K847
gp130 (rat) EEDFVRLKQQQVSDH K848
S853-p
VRLkQQIsDHISQSC
0 1
gp130 (human) VRLkQQIsDHISQSC S853-p
gp130 iso2 (human) gap -
gp130 iso3 (human) VRLKQQISDHISQSC S792
gp130 iso4 (human) gap -
gp130 (mouse) RLKQQQVSDHISQPY S852
gp130 (rat) RLKQQQVSDHISEPY S853
T890-p
GQVERFEtVGMEAAt
Upstream
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • PKCD (human)
Putative in vivo kinases:
  • PKCD (human)
gp130 (human) GQVERFEtVGMEAAt T890-p
gp130 iso2 (human) gap -
gp130 iso3 (human) GQVERFETVGMEAAT T829
gp130 iso4 (human) gap -
gp130 (mouse) GQMERFESVGMETTI S889
gp130 (rat) GQIERFESVGMETAM S890
T897-p
tVGMEAAtDEGMPKS
0 1
gp130 (human) tVGMEAAtDEGMPKS T897-p
gp130 iso2 (human) gap -
gp130 iso3 (human) TVGMEAATDEGMPKS T836
gp130 iso4 (human) gap -
gp130 (mouse) SVGMETTIDEEIPKS I896
gp130 (rat) SVGMETAMDEDISKS M897
Y905-p
DEGMPKSyLPQtVRQ
Downstream
2 20
Effects on Biological Processes:
  • cell cycle regulation
  • transcription, altered
gp130 (human) DEGMPKSyLPQtVRQ Y905-p
gp130 iso2 (human) gap -
gp130 iso3 (human) DEGMPKSYLPQTVRQ Y844
gp130 iso4 (human) gap -
gp130 (mouse) DEEIPKSYLPQTVRQ Y904
gp130 (rat) DEDISKSYLPQTVRQ Y905
T909-p
PKSyLPQtVRQGGyM
0 1
gp130 (human) PKSyLPQtVRQGGyM T909-p
gp130 iso2 (human) gap -
gp130 iso3 (human) PKSYLPQTVRQGGYM T848
gp130 iso4 (human) gap -
gp130 (mouse) PKSYLPQTVRQGGYM T908
gp130 (rat) SKSYLPQTVRQGGYM T909
Y915-p
QtVRQGGyMPQ____
Downstream
2 8
Effects on Biological Processes:
  • cell cycle regulation
  • transcription, altered
gp130 (human) QtVRQGGyMPQ____ Y915-p
gp130 iso2 (human) gap -
gp130 iso3 (human) QTVRQGGYMPQ____ Y854
gp130 iso4 (human) gap -
gp130 (mouse) QTVRQGGYMPQ____ Y914
gp130 (rat) QTVRQGGYMPQ____ Y915